Exchange: NASDAQ
Industry: Biotechnology
Last Trade: 4:00 PM ET 2/9/2012
Last 10 Quotes:
What's This?
Find a Broker »
- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.06 | 0.90 | 17.78 |
| EPS, GAAP | 0.52 | 0.56 | -7.14 |
| Consensus Estimate | 1.03 | 0.86 | 19.77 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.74 | 3.73 | 0.27 |
| EPS, GAAP | 1.91 | 1.89 | 1.06 |
| Consensus Estimate | 3.70 | NA | NA |
| LIFE | Industry Average | |
| P/E (TTM) | 26.04 | 86.30 |
| P/E (Forward) | 12.31 | -4.90 |
| PEG Ratio | 1.53 | -0.30 |
| Price/Sales | 2.51 | 4.64 |
| Beta | 0.88 | 0.71 |
| 2/8/2012 | Just the facts, Fool. (The Motley Fool) |
| 2/7/2012 | Illumina: CEO in Line For Payday If Takeover Costs Him Job (WSJ.com) |
| 2/7/2012 | Disney shares down, SGI sinks after hours (MarketWatch.com) |
| 1/31/2012 | Meet Roche's Candidates for Illumina's Board (WSJ.com) |
| 1/28/2012 | 24/7 Wall St. Top Analyst Calls of the Week (T, ADP. BBY, CHK, DNDN, ETFC, JCP, JPM, GS, MS, JEF, KLAC, LIFE, MCD, KORS, NFLX, VPRT, ZNGA) (24/7 Wall St) |
| 1/26/2012 | Illumina Takes Poison Pill Approach To Halt Roche's Advances (WSJ.com) |
| 1/26/2012 | Top Analyst Upgrades & Downgrades (ADP, CHK, SCHW, GLW, ETFC, GD, GE, GMCR, NRGM, ITW, LRCX, LIFE, NFLX, NVDA, RYAAY, VALE) (24/7 Wall St) |
| 1/25/2012 | Will Gene Sequencing Soon Be Part of Your Doctor Visit? (WSJ.com) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)